MD, PhD, neurologist & neuroimmunologist at the Mellen Center @ClevelandClinic. From 🇭🇷, now in 🇺🇸 Posts=my own
Cleveland, OH
Joined November 2015
- Tweets1.1K
- Following1.2K
- Followers621
- Likes4.4K
More on 2024 MS diagnostic criteria at the Mellen Update 2025:
@DanOntaneda
provided an overview, while I presented the application. +other excellent lectures from the same event
@mssociety @ACTRIMS @ECTRIMS
#MultipleSclerosis LINK shorturl.at/hzOa5
Thankful and lucky for all the collaborators, supporters, and excellent mentorship, which led to final manifestation of this dissertation. 🍀🍀
Congratulations to @Karl0CB for a successful defense of his PhD. An honor to be his advisor. Getting a PhD in Residency and Fellowship is no small feat 5 papers will come from his thesis. Important work that helped get CVS in DXcriteria @ClevelandClinic @BlakeBuletko @CLENeurons
Karlo Toljan retweeted
Very nice work by @Karl0CB and the entire CAVS-MS team @PascalSati @takishinohara @danielsaloreich We will see similar results from @nikosevangelou3 and DECISIVE soon! This data was used to get CVS into the McDonald criteria!
There is similar diagnostic performance of simplified central vein sign #CVS methods (i.e., Select-6) and oligoclonal bands #OCB for the diagnosis of #MultipleSclerosis.
CAVS-MS pilot study from @Karl0CB @DanOntaneda @ClevelandClinic ▶️ journals.sagepub.com/doi/ful…
Standing on the shoulders of the team, and mostly on my mentor's @DanOntaneda Hope I'm not too heavy ;) The way to go is CVS and PRL!
Congratulations to @Karl0CB for receiving an award at our NI CCF training day @CLENeurons @ClevelandClinic important work on central vein and paramagnetic rims. Couldn’t be prouder! Congrats! Special thanks to collaborators @PascalSati @danielsaloreich @takishinohara
Karlo Toljan retweeted
New studies point to potential for greater reliance on objective imaging biomarkers for accurate diagnosis of multiple sclerosis: cle.clinic/44qIzhS
Tools of the trade!
Last official day of residency at @CLENeurons @ClevelandClinic
Looking back at some numbers over 2 senior years; patients I have encountered during inpatient rotations:
- nights: 201
- acute stroke: 177
- 24h call: 117
- consult: 111
- gen neuro: 84
- stroke: 61
- neurohospitalist: 59
- NICU: 55
- epilepsy: 54
- pediatric: 35
= 954
+ as a moonlighter: 139
+ many more in clinic and as a jr resident
Thanks to many teachers and colleagues at Main: @BlakeBuletko @maryannmays11
Ready for fellowship across the street at Mellen! @DanOntaneda
MSTU going strong through ice, snow, and winds during holidays, and the team ready in house❄️🚑🧠 @CLENeurons @shazamhussain @BlakeBuletko @andrewrussman
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Privilage to work with the group and @DanOntaneda as primary mentor. More ahead! Qualitative, not just quantitative, neuroimaging biomarkers in #MultipleSclerosis @ECTRIMS @ACTRIMS @mssociety
This was excellent work done by @Karl0CB in the NAIMS CAVS-MS pilot team effort with @PascalSati @takishinohara @danielsaloreich and Andy Solomon. Also our prospective multi center study is fully enrolled!
PwMS as primary beneficiaries of MS research. Understanding information as empowerment. HT to organizers @MarTintore and @DanOntaneda among panelists @mssociety @mssocietyuk @MSSocietyCanada #MultipleSclerosis
This year ECTRIMS is ensuring the latest MS research unveiled at our congress reaches the entire #MS community. The ECTRIMS 2022: For People with MS Event is now available for viewing in English, Dutch, French, German, Italian & Spanish.
Watch it now ➡️ bit.ly/3FfWVHf
Karlo Toljan retweeted
Congratulations Lynn Daboul @harvardneuromds @CleClinicLCM on this important work showing the effect of GBCA on CVS detection. The first paper of the NAIMS CAVS Pilot study. ajronline.org/doi/abs/10.221… Collaborative work under @PascalSati @danielsaloreich @takishinohara @QMENTA_Inc
Very happy and grateful I could start with PhD studies this July. Grateful for the supportive environment provided by leadership, mentors, and colleagues. We are all making it happen 😇🧠📚 @CLENeurons @BlakeBuletko @maryannmays11 @DanOntaneda
PhDs can be challenging and public discourse tends to focus on the negatives.
To bring back some balance and positive momentum, this group of students sought to highlight the positive elements of the PhD experience. #AcademicChatter #PhDChat elifesciences.org/articles/8…
ALT Detailed venn diagram showing the three primary benefits of doing a PhD: acquiring expertise (pink circle), learning to work in a collaborative environment (blue), and developing communication skills for sharing knowledge (yellow).
Golden hour or in this case, golden minute! We always go fast for acute stroke assessments at @ClevelandClinic. Same day TNKx2 ⏰💉🧠🥇🥈@CLENeurons @BlakeBuletko @shazamhussain @andrewrussman @BustaClot
Succinct review I gladly shared with my co-residents @CLENeurons Should also be an excellent reference for many non-neuro rotators on our services & students. Table 2- key takeaways for assessment/plan👌. Inspired some memes🙃😅 @BlakeBuletko @maryannmays11 @PayalPSoniMD
#TBT #History of #Neurology and Monrad-Krohn’s comment re appropriate reflex ‘hammers’. Blasphemy or just lost art of the legends? @ajlees @LyellJ @joagom @DanOntaneda @FredLepore @CLENeurons
Grateful to have had the opportunity to visit @cemcat_em and witness the world class clinical and research environment. Such a dedicated and inspiring crew striving for excellence in MS care @XMontalban @J_SastreGarriga @MarTintore @DanOntaneda #MultipleSclerosis
Congrats to dear colleague @ceswetlik for presenting at Neuro Institute research day; LGI1 encephalitis - epilepsy/seizure and neuropsych outcomes @CLENeurons @VineetPuniaMD @AKunchok @maryannmays11 @encephalitis @ae_society @ANG_Oxford
Karlo Toljan retweeted
Great work by @candidekarlo presenting our report of COVID vaccination and new onset of MS. @ACTRIMS @doc_RohitBakshi @AKunchok
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure jni-journal.com/article/S016…
